(2E)-1-(3-chlorophenyl)-3-(4-chlorophenyl)prop-2-en-1-one, 95.0%, 10g

(+/-)-Thalidomide, 98%, 250mg

Z-His-OH, 98%, 10g

4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-benzamide, 95.0%, 10g

2-Amino-3-hydroxy-3-(thiophen-2-yl)propanoic acid, 95.0%, 250mg

3-cyclopentyl-1-(2-methylpiperazin-1-yl)propan-1-one, 95.0%, 1g

Diethyl 3-oxopentanedioate, 95.0%, 500g

2-Morpholino-6-oxo-1,6-dihydropyrimidine-4-carboxylic acid, 97%, 10g

3-Bromo-5-methylimidazo[1,2-a]pyridine-2-carbaldehyde, 97%, 100mg

3-Bromo-1-methyl-1H-pyrazole-4-carbaldehyde, 98%, 500mg

2,2,6,6-TETRAMETHYLTETRAHYDRO-2H-PYRAN-4-AMINE, 95.0%, 250mg

GC-Kapillarsäule ROTI®Cap-1, unpolar, L 12 m, Ø-Innen 0,20 mm, Filmd. 0,35 µm, 1 Stück

tert-Butyl 6-hydroxy-2-azaspiro[3.3]heptane-2-carboxylate, 95.0%, 25g